R. G. Dietzgen, C. H. Calisher, G. Kurath, I. V. Kuzmin, and L. L. Rogriguez, Rhabdoviridae. In: Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses, pp.654-680, 2011.

C. M. Freuling, M. Beer, F. J. Conraths, S. Finke, and B. Hoffmann, Novel lyssavirus in a Natterer's bat, Germany. Emerg Infect Dis, vol.17, pp.1519-1522, 2011.

D. A. Marston, D. L. Horton, C. Ngeleja, K. Hampson, and L. M. Mcelhinney, Ikoma lyssavirus, highly divergent novel lyssavirus in an african civet, Emerg Infect Dis, vol.18, pp.664-667, 2012.

D. A. Marston, Complete genomic sequence of Ikoma lyssavirus, J. Virol, vol.86, issue.18, pp.10242-10243, 2012.

N. Johnson, A. Vos, C. Freuling, N. Tordo, and A. Fooks, Human rabies due to lyssavirus infection of bat origin, Vet Microbiol, vol.142, pp.151-159, 2010.

, World Health Organization. WHO Expert Consultation on Rabies, Second report, 2013.

M. C. Schneider, P. C. Romijn, W. Uieda, H. Tamayo, and D. F. Da-silva, Rabies transmitted by vampire bats to humans: an emerging zoonotic disease in Latin America?, Rev Panam Salud Publica, vol.25, pp.260-269, 2009.

C. E. Rupprecht, C. A. Hanlon, and T. Hamachudha, Rabies re-examined, Lancet Infect Dis, vol.2, pp.327-343, 2002.

A. Belotto, L. F. Leanes, M. C. Schneider, H. Tamayo, and E. Correa, Overview of rabies in the Americas, Virus Res, vol.111, pp.5-12, 2005.

, The 14th Meeting of Directors of National Programs for Rabies Control in Latin America (REDIPRA), 2013.

D. G. Streicker, S. Recuenco, W. Valderrama, G. Benavides, J. Vargas et al., Ecological and anthropogenic drivers of rabies exposure in vampire bats: implications for transmission and control, Proc Biol Sci, vol.279, pp.3384-3392, 2012.

D. N. Lee, M. Pape?, and R. A. Van-den-bussche, Present and potential future distribution of common vampire bats in the americas and the associated risk to cattle, PLoS ONE, vol.7, p.42466, 2012.

E. Da-rosa, I. Kotait, T. Barbosa, M. L. Carrier, and P. E. Brandão, Bat-transmitted human rabies outbreaks, Brazilian Amazon, Emerg Infect Dis, vol.12, pp.1197-202, 2006.

. Brasil, . Ministé, and . Da-saúde, Departamento de Vigilância Epidemiológica. Normas té cnicas de profilaxia da raiva humana / Ministé rio da Saú de, Secretaria de Vigilância em Saú de, Departamento de Vigilâ ncia Epidemioló gica.-Brasília: Ministério da Saúde, 2011.

, World Health Organization (WHO). (2010) Rabies vaccines: WHO position paper, Wkly Epidemiol Rec, vol.85, pp.309-320

J. S. Smith, P. A. Yager, and G. M. Baer, A Rapid Fluorescent Focus Inhibition Test (RFFIT) for determining rabies virus-neutralizing antibody, Meslin FX, Kaplan MM, Koprowski H. Laboratory techniques in rabies-WHO, pp.181-192, 1996.

F. Cliquet, M. Aubert, and L. Sagné, Development of a fluorescent antibody virus neutralizing test (FAN test) for the quantitation of rabies-neutralising antibody, J Immunol Meth, vol.212, pp.79-87, 1998.

M. F. Almeida, L. F. Martorelli, C. C. Aires, R. F. Barros, and E. Massad, Vaccinating the vampire bat Desmodus rotundus against rabies, Virus Res, vol.137, issue.2, pp.275-282, 2008.

L. J. Costa and M. E. Fernandes, Rabies: Knowledge and Practices Regarding Rabies in Rural Communities of the Brazilian Amazon Basin, PLoS Negl Trop Dis, vol.10, issue.2, p.4474, 2016.

D. J. Briggs, D. W. Dreesen, U. Nicolay, J. E. Chin, and R. Davis, Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons, Vaccine, vol.19, pp.1055-1060, 2000.

A. Sabchareon, P. Chantavanich, S. Pasuralertsakul, C. Pojjaroen-anant, and V. Prarinyanupharb, Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine, Pediatr Infect Dis J, vol.17, pp.1001-1007, 1998.

A. Strady, J. Lang, M. Lienard, C. Blondeau, and R. Jaussaud, Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy, J. Infect Dis, vol.177, pp.1290-1295, 1998.

D. J. Briggs, A. Banzhoff, U. Nicolay, S. Sirikwin, and B. Dumavibhat, Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine, Bull World Health Organ, vol.78, pp.693-698, 2000.

C. Lau and J. Sisson, The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic, J Travel Med, vol.9, pp.285-288, 2002.

L. F. Cook, Sexual dimorphism of humoral immunity with human vaccines, Vaccine, vol.26, pp.3551-3555, 2008.

R. J. Welch, A. Bl, and C. M. Litwin, An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies, J Med Microbiol, vol.58, pp.806-810, 2009.

L. D. Elmgren and A. I. Wandeler, Competitive ELISA for the detection of rabies virus-neutralizing antibodies, In: Meslin FX; Kaplan MM, 1996.

H. Koprowski, Laboratory techniques in rabies-WHO, pp.193-199

, Persistence of Post-Vaccination Rabies Antibodies in a Brazilian Population PLOS Neglected Tropical Diseases, 2016.